Oncternal Therap Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 150 | $198 | 0.00% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 15 | $8 | 0.00% | 0.00% |
| NEMES RUSH GROUP LLC | 02/12/2025 | 3 | $2 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| PASADENA PRIVATE WEALTH, LLC | 02/03/2025 | 0 | $0 | -100.00% | 0.00% |
| LINDBROOK CAPITAL, LLC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| QUANTUM PRIVATE WEALTH, LLC | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK, INC. | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oncternal Therap institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Oncternal Therap. The most heavily invested institutionals were:
BlackRock Inc.: 39,278
Column Capital Advisors, LLC: 1,450
DOWLING & YAHNKE LLC: 150,464
Amalgamated Financial Corp.: 5,328
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 0
XTX MARKETS LLC: 10,754
0.01% of Oncternal Therap stock is owned by institutional investors.
Institutional investors have bought a total of 207.27 K shares in the last 24 months. This purchase volume represents approximately $109.86 K in transactions.